1. Home
  2. JAGX vs YQ Comparison

JAGX vs YQ Comparison

Compare JAGX & YQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

BUY

Current Price

$6.90

Market Cap

4.9M

Sector

Health Care

ML Signal

BUY

YQ

17 Education & Technology Group Inc.

HOLD

Current Price

$3.52

Market Cap

22.2M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAGX
YQ
Founded
2013
2012
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
22.2M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
JAGX
YQ
Price
$6.90
$3.52
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $60.00
N/A
AVG Volume (30 Days)
★ 1.9M
69.5K
Earning Date
04-07-2026
06-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 82.42
N/A
EPS
N/A
★ N/A
Revenue
★ $11,511,000.00
N/A
Revenue This Year
$61.58
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.20
$1.68
52 Week High
$41.53
$6.45

Technical Indicators

Market Signals
Indicator
JAGX
YQ
Relative Strength Index (RSI) 52.26 56.34
Support Level $0.89 $3.26
Resistance Level $8.00 $3.68
Average True Range (ATR) 3.79 0.40
MACD 1.32 -0.03
Stochastic Oscillator 15.55 45.00

Price Performance

Historical Comparison
JAGX
YQ

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

About YQ 17 Education & Technology Group Inc.

17 Education & Technology Group Inc is engaged in providing education and education technology services in the People's Republic of China (PRC) with a focus on the Teaching and Learning SaaS offerings. It offers smart, in-school, teaching and learning SaaS offerings assist students, teachers, schoolmasters and educational authorities across China. It also offer other educational products and services that complement students' in-school learning. Geographically group operates in China.

Share on Social Networks: